News

Company   ImmuPharma PLC
TIDM         IMM
Headline     Share Options
Released    12:32 04-Feb-2009
Number     7889M12

FOR IMMEDIATE RELEASE

London, 04 February 2009

Grant of Options

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, granted today share options to certain of its employees and Directors. The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme. The amount of options granted are summarised in the following table:

Director	Options Granted
Richard Warr	140,000
Robert Zimmer	150,000
Dimitri Dimitriou	140,000
Franco di Muzio	100,000
Ajay Agrawal	100,000

The share options provide the right to subscribe for ordinary shares of 10 pence each in the Company at a price of 86.5 pence each, the closing middle market price on 3 February 2009. The options are exercisable between 3 years and 10 years from the date of grant.

For further information please contact:

ImmuPharma PLC

Dimitri Dimitriou, Chief Executive Officer                        +44 20 7152 4080
Richard Warr, Chairman                                                +44 20 7152 4080
Dr Robert Zimmer, President & Chief Scientific Officer      + 33 389 32 7650

Panmure Gordon & Co

Andrew Burnett / Rakesh Sharma (Corporate Finance) +44 20 7459 3600

Buchanan Communications +44 20 7466 5000

Lisa Baderoon
Rebecca Skye Dietrich